Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Bayer Healthcare’s blockbuster drug Yaz has come under fire in recent years for its potential to cause a spectrum of health problems. Bayer has downplayed these serious risks while drawing attention to some of the drug’s other uses as treatments for acne and the emotional and physical symptoms associated with premenstrual dysphoric disorder (PMDD). Adding to the confusion is a series of clinical tests designed to quantify the drug’s safety risks. Results of the studies have both supported cast doubt on the claims of women who say they have been harmed by Yaz. With your health and possibly your life at stake, who do you trust?

Read the rest of this entry »